Supplier News Breaks Archives
McNeil recalls OTC infant, children's liquid medicines
May 3rd, 2010
FORT WASHINGTON, Pa. – McNeil Consumer Healthcare has issued a voluntary recall of certain over-the-counter liquid medicines for infants and children, including Tylenol, Motrin, Zyrtec and Benadryl brand products.
The company, which announced the move Friday, said the recall was made in consultation with the Food and Drug Administration and covers as-yet unexpired lots of certain OTC products made in the United States and distributed in the United States, Canada, Dominican Republic, Dubai (UAE), Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad & Tobago, and Kuwait.
McNeil stated the recall was enacted because some of the products "may not meet required quality standards" and that the move "is not being undertaken on the basis of adverse medical events."
As a precautionary measure, McNeil advised parents and caregivers against administering the affected products to children. The company said some of the products being recalled may contain a higher concentration of active ingredient than specified, others may contain inactive ingredients that may not meet internal testing requirements, and others may contain tiny particles.
Products being recalled included various sizes and flavors of Tylenol Infant Drops, Children's Tylenol Suspensions, Children's Tylenol Plus Suspensions, Motrin Infant Drops, Children's Motrin Suspensions, Children's Motrin Cold Suspensions, Children's Zyrtec Liquids in bottles, and Children's Benadryl Allergy Liquids in bottles. A full list of the recalled items is available on the McNeil Consumer Healthcare product recall web site, and more information on the recall is available at 1-888-222-6036.
McNeil added that it's conducting a comprehensive quality assessment across its manufacturing operations and has identified corrective actions that will be implemented before new manufacturing is initiated at the plant where the recalled products were made.
On Monday, CVS Caremark Corp. reported that its CVS/pharmacy stores have completed the recall issued by McNeil.
The drug store chain said it implemented its product removal procedures for the affected items on Friday evening at all of its stores and, to further protect customers, placed a block in its store register system to prevent the sale of any of the recalled items.